Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000273216 is a novel, uncharacterized sense noncoding RNA transcript located in the intronic region of the *RAS Like Family 10 Member A* (RASL10A) gene[1][5][9]. There is no evidence to suggest it encodes a protein or that it functions as a therapeutic target. The molecular classification would likely be designated as "long noncoding RNA" (lncRNA) or generic "noncoding RNA," pending further characterization, although neither its biological functions nor its potential involvement in disease have been annotated. The gene's description is primarily based on its genomic location and lack of protein-coding capability; it is distinct from RASL10A itself, which is a small GTPase with known roles in cell signaling and disease[3][7][9].
None (no mechanisms of action as a therapeutic target, since no drugs interact with it)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to RASL10A (ENSG00000273216).